Results 191 to 200 of about 14,252 (257)

Microstructural Characterization of Dry Powder Inhaler Formulations Using Orthogonal Analytical Techniques. [PDF]

Pharm Res
Farias G, Ganley WJ, Price R, Conti DS, Mangal S, Bielski E, Newman B, Shur J.   +7 more
europepmc   +1 more source

Budesonide-Formoterol Metered-Dose Inhaler vs Fluticasone-Salmeterol Dry-Powder Inhaler.

JAMA Intern Med
Rabin AS, Seelye SM, Weinstein JB, Hogan CK, Whittington TN, Cano J, Miller SA, Kelley C, Prescott HC.   +8 more
europepmc   +1 more source

Development of Novel Fluticasone/Salmeterol/Tiotropium-Loaded Dry Powder Inhaler and Bioequivalence Assessment to Commercial Products in Rats. [PDF]

Pharmaceutics
Cho H, Lee H, Hwang D.
europepmc   +1 more source

Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care. [PDF]

Clin Drug Investig
Capstick TGD, Gudimetla S, Harris DS, Malone R, Usmani OS.   +4 more
europepmc   +1 more source

Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies. [PDF]

Daru
Islam N, Suwandecha T, Srichana T.
europepmc   +1 more source

Dry Powder Inhaler Formulation of Lactobacillus rhamnosus GG Targeting Pseudomonas aeruginosa Infection in Bronchiectasis Maintenance Therapy. [PDF]

Pharmaceutics
Tran TT, Cheow WS, Pu S, Park JW, Hadinoto K.   +4 more
europepmc   +1 more source

Inhaler personalisation based on peak inspiratory flow (PIF) among dry powder inhaler users: a pilot randomised control trial (RCT) in COPD. [PDF]

J Pharm Policy Pract
Jailaini MFM, Muneswarao J, Hao CZ, Hussain R, Hamid MFA.   +4 more
europepmc   +1 more source

Patient considerations in the treatment of COPD: Focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol [PDF]

, 2018
Calabrese, Giovanna, Maniscalco, Mauro, Molino, Antonio   +2 more
core   +1 more source

Implementation of a Metered-Dose Inhaler to Dry-Powder Inhaler National Formulary Transition.

JAMA Netw Open
Rabin AS, Weinstein JB, Whittington TN, Hogan CK, Khachikian D, Seelye SM, Prescott HC.   +6 more
europepmc   +1 more source